πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

85 results for β€œRhythm” Clear

  1. CRT with triple site ventricular stimulation

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 3 other completed

    1 trial

  2. Class I or III Antiarrhythmic Medications

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    phase 3 small molecule completed

    1 trial

  3. Coronary artery bypass grafting

    Rhythm Pharmaceuticals Netherlands B.V.

    Ischemic Heart Failure

    phase 3 other completed

    1 trial

  4. Flecainide or Sotalol or Propafenone

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    phase 3 small molecule completed

    1 trial

  5. Medtronic Talent Stent-Graft-System

    Rhythm Pharmaceuticals Netherlands B.V.

    Aortic Diseases

    phase 3 other completed

    1 trial

  6. RANOLAZINE, FLECARDIA Διάλυμα Ξ³ΞΉΞ± ένΡση/έχχυση

    Pharma Mar S.A.

    Restoration of sinus rhythm in patients with recent AF onset

    phase 3 small molecule active

    1 trial

  7. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Pro-opiomelanocortin (POMC) Deficiency Obesity

    phase 3 small molecule completed

    1 trial

  8. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypothalamic Obesity

    phase 3 small molecule active

    3 trials

  9. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Obesity Associated With Defects in Leptin-melanocortin Pathway

    phase 3 small molecule active

    2 trials

  10. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Bardet Biedl Syndrome (BBS)

    phase 3 small molecule completed

    1 trial

  11. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Leptin Receptor Deficiency Obesity

    phase 3 small molecule completed

    1 trial

  12. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Bardet-Biedl Syndrome

    phase 3 small molecule completed

    1 trial

  13. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Obesity

    phase 3 small molecule active

    1 trial

  14. Setmelanotide 2 mg

    Rhythm Pharmaceuticals Netherlands B.V.

    Bardet-Biedl Syndrome

    phase 3 small molecule completed

    1 trial

  15. Ventricular Assist Device System

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 3 other completed

    1 trial

  16. Atorvastatina Teva Italia 80 mg compresse rivestite con film, Film-coated tablets, white, shaped elliptical, and coated with smooth film. The dimensions of each tablet are approximately 18.8 mm x 10.3 mm (identical to those containing atorvastatin).

    Cardiol Therapeutics

    Arrhythmogenic Cardiomyopathy (ACM)

    phase 2 small molecule active

    1 trial

  17. Bivamelagon

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypothalamic Obesity

    phase 2 small molecule active

    1 trial

  18. Diuretics

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 2 small molecule completed

    1 trial

  19. LB54640

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypothalamic Obesity

    phase 2 small molecule completed

    1 trial

  20. LX2020

    Lexeo Therapeutics

    Arrhythmogenic Cardiomyopathy

    phase 2 gene therapy active

    1 trial

  21. Medtronic PrimeADVANCED Neurostimulator

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 2 other completed

    1 trial

  22. PCI

    Rhythm Pharmaceuticals Netherlands B.V.

    Myocardial Infarction

    phase 2 other completed

    1 trial

  23. Part A: RM-718 or placebo (matched to specific RM-718 dose cohort)

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypothalamic Obesity

    phase 2 small molecule active

    1 trial

  24. Ramelteon

    Takeda Pharmaceuticals International AG

    Sleep Disorders, Circadian Rhythm

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources